Bioequivalence of a Zanubrutinib Tablet Compared to Capsules in Healthy Adult Participants
NCT05767398
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
58
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
Zanubrutinib
Sponsor
BeiGene